FDA Warning Letter — Hospira, Inc.
The FDA took a Warning Letter action against Hospira, Inc. on February 14, 2017 (Mcpherson, KS). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Hospira, Inc.
- Date
- February 14, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Mcpherson, KS (United States)